Jason David Sawyer is Chief Executive Officer of First Wave BioPharma, Inc.. Currently has a direct ownership of 40,000 shares of FWBI, which is worth approximately $39,600. The most recent transaction as insider was on Dec 22, 2025, when has been sold 40,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40K
n/a 3M change
n/a 12M change
Total Value Held $39,600

Jason David Sawyer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 22 2025
BUY
Grant, award, or other acquisition
-
40,000 Added 50.0%
40,000 Common Stock

Also insider at

LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Healthcare
JDS

Jason David Sawyer

Chief Executive Officer
Pasadena, CA

Track Institutional and Insider Activities on FWBI

Follow First Wave BioPharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FWBI shares.

Notify only if

Insider Trading

Get notified when an First Wave Bio Pharma, Inc. insider buys or sells FWBI shares.

Notify only if

News

Receive news related to First Wave BioPharma, Inc.

Track Activities on FWBI